Non-Interventional Study (NIS) Collecting Experiences For IPF in Taiwan

NCT03242759 · clinicaltrials.gov ↗

COMPLETED

Status

101

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Fibrosis

Interventions

DRUG: nintedanib
DRUG: pirfenidone

Sponsor

Boehringer Ingelheim